105 related articles for article (PubMed ID: 12355899)
21. Beneficial effect of therapeutic infusion of nafamostat mesilate (FUT-175) on hemodynamics in experimental acute pancreatitis.
Dobosz M; Sledzinski Z; Juszkiewicz P; Babicki A; Stanek A; Wajda Z; Basinski A
Hepatogastroenterology; 1991 Apr; 38(2):139-42. PubMed ID: 1855771
[TBL] [Abstract][Full Text] [Related]
22. Clearance of imipenem/cilastatin in acute renal failure patients treated by continuous hemodiafiltration (CAVHD).
Vos MC; Vincent HH; Yzerman EP
Intensive Care Med; 1992; 18(5):282-5. PubMed ID: 1527259
[TBL] [Abstract][Full Text] [Related]
23. Cefazolin plus ceftazidime versus imipenem/cilastatin monotherapy for treatment of CAPD peritonitis--a randomized controlled trial.
Leung CB; Szeto CC; Chow KM; Kwan BC; Wang AY; Lui SF; Li PK
Perit Dial Int; 2004; 24(5):440-6. PubMed ID: 15490983
[TBL] [Abstract][Full Text] [Related]
24. Prolonged continuous i.v. "desensitization" in Tienam hypersensitivity.
Confino-Cohen R; Goldberg A; Lang R
Allergy; 1997 Jun; 52(6):683-4. PubMed ID: 9226072
[No Abstract] [Full Text] [Related]
25. Efficacy of continuous regional arterial infusion of a protease inhibitor and antibiotic for severe acute pancreatitis in patients admitted to an intensive care unit.
Imaizumi H; Kida M; Nishimaki H; Okuno J; Kataoka Y; Kida Y; Soma K; Saigenji K
Pancreas; 2004 May; 28(4):369-73. PubMed ID: 15097852
[TBL] [Abstract][Full Text] [Related]
26. Aerosolization of imipenem/cilastatin prevents pseudomonas-induced acute lung injury.
Hashimoto S; Wolfe E; Guglielmo B; Shanks R; Sundelof J; Pittet JF; Thomas E; Wiener-Kronish J
J Antimicrob Chemother; 1996 Nov; 38(5):809-18. PubMed ID: 8961050
[TBL] [Abstract][Full Text] [Related]
27. Comparison of 30-min and 3-h infusion regimens for imipenem/cilastatin and for meropenem evaluated by Monte Carlo simulation.
Lee LS; Kinzig-Schippers M; Nafziger AN; Ma L; Sörgel F; Jones RN; Drusano GL; Bertino JS
Diagn Microbiol Infect Dis; 2010 Nov; 68(3):251-8. PubMed ID: 20851549
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetic profiles of intravenous imipenem/cilastatin during slow hemodialysis in critically ill patients.
Kihara M; Ikeda Y; Shibata K; Masumori S; Ebira H; Shiratori K; Ueda S; Takagi N; Umemura S; Shionoiri H
Clin Nephrol; 1994 Sep; 42(3):193-7. PubMed ID: 7994939
[TBL] [Abstract][Full Text] [Related]
29. Early antibiotic treatment (prophylaxis) of septic complications in severe acute necrotizing pancreatitis: a prospective, randomized, multicenter study comparing two regimens with imipenem-cilastatin.
Maraví-Poma E; Gener J; Alvarez-Lerma F; Olaechea P; Blanco A; Domínguez-Muñoz JE;
Intensive Care Med; 2003 Nov; 29(11):1974-80. PubMed ID: 14551680
[TBL] [Abstract][Full Text] [Related]
30. Is high-dose nafamostat mesilate effective for the prevention of post-ERCP pancreatitis, especially in high-risk patients?
Park KT; Kang DH; Choi CW; Cho M; Park SB; Kim HW; Kim DU; Chung CW; Yoon KT
Pancreas; 2011 Nov; 40(8):1215-9. PubMed ID: 21775918
[TBL] [Abstract][Full Text] [Related]
31. Liver injury in acute pancreatitis and mitigation by continuous arterial infusion of an antibiotic via the superior mesenteric artery.
Miyahara S; Isaji S
Pancreas; 2001 Aug; 23(2):204-11. PubMed ID: 11484923
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of parenteral imipenem/cilastatin in patients on continuous ambulatory peritoneal dialysis.
Chan CY; Lai KN; Lam AW; Li PK; Chung WW; French GL
J Antimicrob Chemother; 1991 Feb; 27(2):225-32. PubMed ID: 2055813
[TBL] [Abstract][Full Text] [Related]
33. [Continuous regional arterial infusion of protease inhibitor and antibiotic for severe acute pancreatitis].
Takeda K
Nihon Rinsho; 2004 Nov; 62(11):2101-7. PubMed ID: 15552895
[TBL] [Abstract][Full Text] [Related]
34. Long-term effects of nafamostat and imipenem on experimental acute pancreatitis in rats.
Naruse S; Wang Y; Kitagawa M; Ishiguro H; Seki Y; Ozaki T; Hayakawa T
Pancreas; 2000 Oct; 21(3):290-5. PubMed ID: 11039474
[TBL] [Abstract][Full Text] [Related]
35. [A case of pulmonaly bulla infection with Mycobacterium fortuitum].
Hisamori S; Oida K; Taguchi Y; Tanaka E; Inoue T; Katoh K; Sakuramoto M; Minaguchi M; Maeda Y; Maniwa K; Terada K; Ishimaru H; Hata K
Kansenshogaku Zasshi; 2003 Jun; 77(6):451-5. PubMed ID: 12872695
[TBL] [Abstract][Full Text] [Related]
36. [Selective intra-arterial use of small doses of thienam and vasaprostanin the treatment of suppurative diseases of the foot in patients with diabetes mellitus].
Antsypovich EA; Molchanov VF; Kadyshev IuG; Brusnitsyna MA
Vestn Khir Im I I Grek; 1998; 157(1):76-7. PubMed ID: 9611324
[TBL] [Abstract][Full Text] [Related]
37. Lung abscess (6 cm) of unexplained origin in a 36-year-old woman.
Zazgornik J; Biesenbach G; Schinko H
Wien Med Wochenschr; 2002; 152(17-18):481-2. PubMed ID: 12385075
[TBL] [Abstract][Full Text] [Related]
38. Bile levels of imipenem in patients with T-drain following the administration of imipenem/cilastatin.
Mayer M; Tophof C; Opferkuch W
Infection; 1988; 16(4):225-8. PubMed ID: 3182087
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics in healthy subjects of FCE 22101 and its acetoxymethyl ester, FCE 22891: effect of co-administration of imipenem/cilastatin on the renal metabolism of FCE 22101.
Norrby SR; Burman LA; Sassella D; Corigli R; Cassinelli G; Franceschi G; Dornbusch K
J Antimicrob Chemother; 1990 Mar; 25(3):371-83. PubMed ID: 2338416
[TBL] [Abstract][Full Text] [Related]
40. [Intra-arterial regional perfusion in destructive forms of acute pancreatitis].
Vafin AZ; Baĭchorov EKh; Gol'tiapina IA; Voskanian SE; Kuznetsov OG; Shurshin EM
Vestn Khir Im I I Grek; 1999; 158(1):30-5. PubMed ID: 10491831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
